| HOME >> MEDICINE >> TECHNOLOGY |
Metered Dose Inhalers (MDIs), Dry Powder Inhalers (DPIs) and
Other Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) III-14
Table 21: US Historic Review for Pulmonary Drug Delivery
Technologies by Product Segment - Metered Dose Inhalers
(MDIs), Dry Powder Inhalers (DPIs) and Other Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2001 through 2006 (includes corresponding
Graph/Chart) III-15
Table 22: US 13-Year Perspective for Pulmonary Drug Delivery
Technologies by Product Segment - Percentage Breakdown of
Dollar Sales for Metered Dose Inhalers (MDIs), Dry Powder
Inhalers (DPIs) and Other Markets for 2003, 2009 and 2015
(includes corresponding Graph/Chart) III-15
2. CANADA III-16
A.Market Analysis III-16
Outlook III-16
Product Launch III-16
Strategic Corporate Developments III-16
Akela Pharma Inc - A Key Canadian Player III-16
B.Market Analytics III-17
Table 23: Canadian Recent Past, Current and Future Analysis
for Pulmonary Drug Delivery Technologies by Product Segment -
Metered Dose Inhalers (MDIs), Dry Powd
'/>"/>
| SOURCE Reportlinker Copyright©2010 PR Newswire. All rights reserved |